+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration; Distribution Channel; Application and Geography

  • ID: 4769911
  • Report
  • Region: Global
  • 343 pages
  • The Insight Partners
1 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline plc.
  • Novartis AG
  • Novo Nordisk A/S
  • Terumo Corporation
  • MORE
The global drug delivery systems market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a CAGR of 7.2% from 2019-2027.

The market is driven by the factors such as, rising incidence of chronic diseases, growing demand for non-invasive drug delivery devices, increasing R&D expenditures in and pharmaceutical and medical device companies. However, the factors restraining the market growth are high cost involved in development of drug delivery devices and product recalls.

With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

The traditional drug delivery techniques, like intramuscular, intravenous, oral and rectal drug administration are not suitable to certain patient populations. The non-invasive methods of drug delivery reduces dosing frequency and simplifies dosing schedules. Moreover, non-invasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing cost may also be less for non-invasive dosage forms as compared to injections in many cases. For instance, inhaled insulin appears to be a non-invasive, well-tolerated and liked modality of treatment of diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human) inhalation powder which was approved by FDA. Thus, due to advantages offered by non-invasive drug delivery devices the drug delivery market is expected to witness growth during the forecast period.

Global drug delivery systems market, based on the route of administration was segmented into oral, transmucosal, injectable, topical, implantable, and ocular. Oral drug delivery system segment led the market for drug delivery systems market in 2018, owing to its ease of administration and increasing demand by the patient population for various therapeutic areas. Based on the distribution channels, the drug delivery systems market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies held the major share owing to the availability of larger range of medications required for the treatment of patient population for various medical conditions. On the basis of application, the market is segmented into hospital & clinics, home care settings, and others. The hospitals and clinics segment held the major share in 2018. This is primarily attributed to the significant number of patient visits to hospitals and the requirement of large volumes of drugs and their respective delivery devices to fulfil to the demand of the large patient population.

Some of the major primary and secondary sources included in the report for the drug delivery systems market are World Health Organization, International Society for Aerosols in Medicine (ISAM), National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes UK, Pharmaceutical Research and Manufacturers of America (PhRMA), Inhalation Drug Delivery Association (IDDA), American Lung Association, Centers for Disease Control and Prevention, Chinese Diabetes Society, International Diabetes Federation and others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline plc.
  • Novartis AG
  • Novo Nordisk A/S
  • Terumo Corporation
  • MORE
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Drug delivery systems market - By
1.3.2 Global Drug delivery systems market - By Application
1.3.3 Global Drug delivery systems market - By Distribution Channel
1.3.4 Global Drug delivery systems market - By Geography

2. GLOBAL DRUG DELIVERY SYSTEMS MARKET - KEY TAKEAWAYS

3. RESEARCH METHODOLOGY
3.1 COVERAGE
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH

4. GLOBAL DRUG DELIVERY SYSTEMS- MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 South & Central America - PEST Analysis

5. DRUG DELIVERY SYSTEMS MARKET - KEY MARKET DYANAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Non Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.2 KEY MARKET RESTRAINTS
5.2.1 High Cost Involved In Development Of Drug Delivery Devices
5.2.2 Product Recalls
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Increasing Patient Compliance
5.4 FUTURE TRENDS
5.4.1 Growing New Innovations In Drug Delivery Technology
5.5 IMPACT ANALYSIS

6. DRUG DELIVERY SYSTEMS MARKET - GLOBAL ANALYSIS
6.1 GLOBAL DRUG DELIVERY SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE OF PROMINENT PLAYERS
6.3.1 BD
6.3.2 3 M
6.3.3 GlaxoSmithKline plc.
6.3.4 Novartis AG

7. DRUG DELIVERY SYSTEMS MARKET - GLOBAL REGULATORY SCENARIO
7.1 NORTH AMERICA
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 EUROPE
7.3 ASIA PACIFIC
7.3.1 Japan
7.3.2 China
7.3.3 India
7.4 MIDDLE EAST & AFRICA
7.4.1 Saudi Arabia
7.4.2 South Africa
7.5 SOUTH & CENTRAL AMERICA
7.5.1 Brazil

8. DRUG DELIVERY SYSTEMS MARKET ANALYSIS AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1 OVERVIEW
8.2 ROUTE OF ADMINISTRATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3 ORAL DRUG DELIVERY MARKET
8.3.1 Overview
8.3.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Solid Oral Drugs Market
8.3.3.1 Overview
8.3.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3.3 SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.4 Liquid Oral Drugs Market
8.3.4.1 Overview
8.3.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.4.3 Liquid Oral Drugs MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.5 Semi-solid Oral Drugs Market
8.3.5.1 Overview
8.3.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.5.3 SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4 TRANSMUCOSAL DRUG DELIVERY MARKET
8.4.1 Overview
8.4.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
SOURCE: THE PUBLISHER ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.4.3 Pulmonary Drug Delivery Market
8.4.3.1 Overview
8.4.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.3 PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.4 In-metered Dose Inhalers Market
8.4.3.4.1 Overview
8.4.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.4.3 IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.5 Dry Powder Inhalers Market
8.4.3.5.1 Overview
8.4.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.5.3 DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.6 Nebulizers Market
8.4.3.6.1 Overview
8.4.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.6.3 NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4 Nasal Drug Delivery Market
8.4.4.1 Overview
8.4.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.3 NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.4 Nasal Spray Market
8.4.4.4.1 Overview
8.4.4.4.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.4.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.5 Nasal Drops Market
8.4.4.5.1 Overview
8.4.4.5.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.5.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.6 Nasal Gel Market
8.4.4.6.1 Overview
8.4.4.6.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.6.3 NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
SOURCE: THE PUBLISHER ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.4.5 Buccal Drug Delivery Market
8.4.5.1 Overview
8.4.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.5.3 BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.6 Sublingual Drug Delivery Market
8.4.6.1 Overview
8.4.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.6.3 SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.7 Rectal Transmucosal Drug Delivery Market
8.4.7.1 Overview
8.4.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.7.3 RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.8 Vaginal Transmucosal Drug Delivery Market
8.4.8.1 Overview
8.4.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.8.3 VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5 TOPICAL DRUG DELIVERY MARKET
8.5.1 Overview
8.5.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3 Semi-solid Topical Drug Delivery Formulations Market
8.5.3.1 Overview
8.5.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3.3 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.4 Liquid Topical Drug Delivery Formulations Market
8.5.4.1 Overview
8.5.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.4.3 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.5 Solid Topical Drug Delivery Formulations Market
8.5.5.1 Overview
8.5.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.5.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.6 Transdermal Patches Market
8.5.6.1 Overview
8.5.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
8.5.6.3 TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.7 Transdermal Gels Market
8.5.7.1 Overview
8.5.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
8.5.7.3 TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.8 Others Market
8.5.8.1 Overview
8.5.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8.5.8.3 OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6 INJECTABLE DRUG DELIVERY MARKET
8.6.1 Overview
8.6.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
SOURCE: THE PUBLISHER ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.6.3 Conventional Injection Devices Market
8.6.3.1 Overview
8.6.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.3.3 CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4 Self-Injection Devices Market
8.6.4.1 Overview
8.6.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.3 SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.4 Needle Free Injectors Market
8.6.4.4.1 Overview
8.6.4.4.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.4.3 NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.5 Pen injectors Market
8.6.4.5.1 Overview
8.6.4.5.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.5.3 PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.6 Wearable Injectors Market
8.6.4.6.1 Overview
8.6.4.6.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.6.3 WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7 IMPLANTABLE DRUG DELIVERY MARKET
8.7.1 Overview
8.7.2 Implantable drug delivery Market Revenue and Forecast to 2027 (US$ Mn)
SOURCE: THE PUBLISHER ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.7.3 Active Implantable Market
8.7.3.1 Overview
8.7.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.3.3 ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.4 Passive Implantable Market
8.7.4.1 Overview
8.7.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.4.3 Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8 OCULAR DRUG DELIVERY MARKET
8.8.1 Overview
8.8.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
SOURCE: THE PUBLISHER ANALYSIS, PRIMARY INTERVIEWS, SECONDARY SOURCES
8.8.3 Eye Drops and Sprays Market
8.8.3.1 Overview
8.8.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
8.8.3.3 Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.4 Gels & Ointments Market
8.8.4.1 Overview
8.8.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
8.8.4.3 Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.5 Ocular Inserts Market
8.8.5.1 Overview
8.8.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
8.8.5.3 Occular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.6 Drug Coated Contact Lens Market
8.8.6.1 Overview
8.8.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
8.8.6.3 Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9. GLOBAL DRUG DELIVERY SYSTEMS MARKET ANALYSIS- BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY DISTRIBUTION CHANNEL 2018 & 2027 (%)
9.3 HOSPITAL PHARMACIES MARKET
9.3.1 Overview
9.3.2 Global Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 RETAIL PHARMACIES MARKET
9.4.1 Overview
9.4.2 Global Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 ONLINE PHARMACIES MARKET
9.5.1 Overview
9.5.2 Global Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10. GLOBAL DRUG DELIVERY SYSTEMS MARKET ANALYSIS- BY APPLICATION
10.1 OVERVIEW
10.2 GLOBAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATON 2018 & 2027 (%)
10.3 HOMECARE SETTINGS MARKET
10.3.1 Overview
10.3.2 Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 HOSPITALS & CLINICS MARKET
10.4.1 Overview
10.4.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 OTHERS MARKET
10.5.1 Overview
10.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • BD (Becton Dickinson & Company)
  • Boston Scientific Corporation
  • Novo Nordisk A/S
  • Bausch Health Companies Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769911
Adroll
adroll